Filing Details
- Accession Number:
- 0001209191-21-005507
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2021-01-26 19:00:01
- Reporting Period:
- 2020-11-17
- Accepted Time:
- 2021-01-26 19:00:01
- Original Submission Date:
- 2020-11-19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1679363 | Morphic Holding Inc. | MORF | Pharmaceutical Preparations (2834) | 473878772 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1779978 | P. Praveen Tipirneni | C/O Morphic Holding, Inc. 35 Gatehouse Drive, A2 Waltham MA 02451 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-17 | 2,713 | $4.32 | 5,999 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-17 | 2,713 | $30.10 | 3,286 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-11-18 | 327 | $4.32 | 3,613 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-18 | 327 | $30.00 | 3,286 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Footnotes
- This amended Form 4 is filed solely to report the inadvertent error in the number of shares held after the initial reported transaction, which inadvertent error was carried through in the subsequent number of shares held following the respective reported transactions. All other information in the Form 4 filed on November 19, 2020 remains the same.
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.25 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
